Refining methods

JP7873274B2Active Publication Date: 2026-06-11QBD QS IP
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2024111813
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2015-11-26
Filing Date
2024-07-11
Publication Date
2026-06-11
Estimated Expiration
2036-11-25

Smart Images

  • Figure 0007873274000005
    Figure 0007873274000005
  • Figure 0007873274000006
    Figure 0007873274000006
  • Figure 0007873274000007
    Figure 0007873274000007
Patent Text Reader

Abstract

To provide a method by which a compound / molecule capable of binding an antigen, such an antibody type compound / molecule, can be purified, extracted, and / or selected.SOLUTION: The method may be used to purify, extract, or select a specific type binding agent from a mixed composition. The method may be used to extract or purify a specific binding agent from a mixed composition that comprises another factor capable of binding another antigen. The method may find particular application as a method for purifying blood group antigen antibody.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Claims

1. A method for purifying antibodies that have specificity for blood group antigens, A step of bringing an antibody source and red blood cells expressing blood group antigens into contact under conditions that enable the blood group antigens expressed by the red blood cells to bind to blood group antigen-specific antibodies in the source, and Steps to isolate bound antibodies Includes, The method wherein the method does not utilize cell membrane fragments or stromas, the source is blood, blood products, serum and / or plasma, and the red blood cells and the source are of the same species.

2. The method according to claim 1, wherein the source is derived from or provided by subjects willing to donate blood (blood donors) and / or subjects immunized to produce antibodies against specific targets.

3. The method according to claim 1 or 2, wherein the antibody is a polyclonal antibody.

4. The method according to any one of claims 1 to 3, wherein the red blood cells are not conjugated to a support, supporting substrate, or polymer.

5. The method according to any one of claims 1 to 4, wherein the step of isolating the bound antibody involves dissociating and / or eluting the antibody adsorbed to or bound to red blood cells.

6. The method according to claim 5, wherein the dissociation and / or elution procedure includes heating, rapid freezing / thawing, ultrasonic bath, cell lysis, acid-based elution / dissociation, chilled acid, organic solvent, xylene, chloroform, improved heating / stirring, and chloroquine diphosphate.

7. The method according to claim 5 or 6, wherein the step of isolating the bound antibody involves contacting the antibody / cell complex with an elution buffer.

8. The method according to claim 7, wherein the elution buffer is formulated to cause dissociation of the antibody by acid elution.

9. The method according to claim 7 or 8, wherein the elution buffer comprises or essentially comprises glycine-HCl and NaCl.

Citation Information

Patent Citations

  • Blood samples or stroma bonded through a diazoamino bond to a polymer

    CA1144858A

  • Test for diagnosis

    JP1987088963A

  • A novel parasitic helminth protein

    JP1996505772A

  • Apparatus and method for simultaneously determining blood group antigens

    JP2009513939A

  • Method for preparing antibody dissociated solution from erythrocyte

    JP2010060416A